AIM:To investigate the efficacy and potential mechanism of Xiaotan Tongfu granules(XTTF)in stress ulcers.METHODS:One hundred sixty rats were randomly divided into 4 groups(n=10)as follows:the model group(MP group),the...AIM:To investigate the efficacy and potential mechanism of Xiaotan Tongfu granules(XTTF)in stress ulcers.METHODS:One hundred sixty rats were randomly divided into 4 groups(n=10)as follows:the model group(MP group),the control group(CP group),the ranitidine group(RP group)and the XTTF granule group(XP group).Rats in the MP group received no drugs,rats in the CP group received 0.2 mL of a 0.9%sodium chloride solution via oral gavage,and rats in the RP and XP groups received the same volume of ranitidine(50 mg/kg)or XTTF granule(4.9 g/kg).The cold-restraint stress model was applied to induce stress ulcers after 7 consecutive days of drug administration.Afterwards,rats were sacrificed at 0,3,6 and24 h.Gastric pH was measured by a precise pH meter;gastric emptying rate(GER)was measured by using a methylcellulose test meal;myeloperoxidase activity(MPO),macrophage migration inhibitory factor(MIF),proliferating cell nuclear antigen(PCNA),and heat shock protein 70(HSP70)were measured by immunohistochemical staining;and mucosal cell apoptosis was measured by transferase dUTP nick end labeling.RESULTS:In the cold-restraint stress model,the development of stress ulcers peaked at 3 h and basically regressed after 24 h.Gastric lesions were significantly different in the RP and XP groups at each time point.Interestingly,although this index was much lower in the RP group than in the XP group immediately following stress induction(7.00±1.10 vs 10.00±1.79,P<0.05.Concerning gastric pH,between the RP and XP groups,we detected a statistically significant difference immediately after stress induction(0 h:4.56±0.47 vs 3.34±0.28,P<0.05)but not at any of the subsequent time points.For GER,compared to the RP group,GER was remarkably elevated in the XP group because a statistically significant difference was detected(3 h:46.84±2.70 vs 61.16±5.12,P<0.05;6 h:60.96±6.71 vs 73.41±6.16,P<0.05;24 h:77.47±3.17 vs 91.31±4.34,P<0.05).With respect to MPO and MIF,comparisons between the RP and XP groups revealed statistically significant di展开更多
Objective. To observe the clinical efficacy and mechanism of Zhuyu Tongfu （逐瘀通腑, ZYTF） Serial Recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage （HCH）. Methods： One...Objective. To observe the clinical efficacy and mechanism of Zhuyu Tongfu （逐瘀通腑, ZYTF） Serial Recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage （HCH）. Methods： One hundred and eighteen patients with hypertensive cerebral hemorrhage, on the basis of conventional Western medicine treatment, were randomly divided into ZYTF combined with acupuncture and massotherapy group （treated group） and simple Western medicine group （control group） ; the clinical efficacy, neurofunction deficit scoring （NDS） alterations and hematoma absorption rate of both groups were observed, and also the plasma superoxide dismutase （SOD） activity, plasma lipid peroxidase （LPO） content, erythrocyte glutathion peroxidase （GSH-Px） activity, hematocrit （Ht） and the whole blood viscosity （Va） change were also observed. Results： In the treated group, the clinical efficacy, NDS improvement and hematoma absorption rate were superior to that of the control group; comparison between the two groups after treatment showed that plasma SOD activity and GSH-Px activity got more elevated and plasma LPO content, Ht and Va more lowered in the the treated group than those in the control group. Cenclusien： ZYTF combined with acupuncture and massotherapy has better effect, its therapeutic mechanism was possibly correlated to the elevation of plasma SOD activity, GSH-Px activity and lowering of plasma LPO content, Ht and Va.展开更多
Objective:To evaluate the efficacy and safety of XuanFei TongFu method in the treatment of sepsis.Methods:The relevant literatures on the treatment of sepsis by Xuanfei Tongfu method,published by PubMed,Medline and th...Objective:To evaluate the efficacy and safety of XuanFei TongFu method in the treatment of sepsis.Methods:The relevant literatures on the treatment of sepsis by Xuanfei Tongfu method,published by PubMed,Medline and the Cochrane library,CNKI,WEIPU Database,WANFANG Database until December 2019 were searched by computer.Revman 5.3 was used to analyze the relevant literatures that met the inclusion and exclusion criteria,and to evaluate the influence of Xuanfei Tongfu method on gastrointestinal function,adverse reactions of gastrointestinal,28 day mortality.Results:a total of 17 randomized controlled clinical trials(RCTS)involving a total of 984 patients were included.Xuanfei Tongfu decoction combined with the control group can improve intestinal function.Xuanfei Tongfu decoction can reduce gastrointestinal adverse reactions,but there is no statistical significance,and reducing mortality of 28 days(RR=0.64,95%CI(0.42,0.99),P=0.04),reducing the APACHEⅡ[SMD=-0.90,95%CI(-1.49,-0.31),P=0.0003],reducing of Il-6[SMD=-0.36,95%CI(-0.62,-0.1),P=0.007],and improving IL-10 were all better than the control group,the difference was statistically significant.Conclusion:The method of Xuanfei Tongfu can enhance the gastrointestinal function,reduce the gastrointestinal adverse reactions,and improve the prognosis of sepsis patients.It may be achieved by regulating the body's immune inflammatory response.展开更多
目的：观察宣肺通腑汤治疗中老年重症肺炎合并胃肠功能障碍的疗效及对胃肠功能的保护作用及对炎症因子的影响。方法：将104例符合要求的患者随机分为对照组和观察组各52例。对照组给予抗感染治疗、抗炎治疗、对症治疗及支持治疗,给予枸...目的：观察宣肺通腑汤治疗中老年重症肺炎合并胃肠功能障碍的疗效及对胃肠功能的保护作用及对炎症因子的影响。方法：将104例符合要求的患者随机分为对照组和观察组各52例。对照组给予抗感染治疗、抗炎治疗、对症治疗及支持治疗,给予枸橼酸莫沙必利口服溶液,10 m L/次,3次/d,口服;双歧杆菌三联活菌散,2 g/次,3次/d,口服。观察组在对照组治疗的基础上给予宣肺通腑汤,1剂/d。两组疗程均连续治疗14 d。记录治疗前后CURB65,SMART-COP,临床肺部感染评分（CPIS）,中医证候评分、胃肠功能障碍（GIDF）,急性病生理和长期健康Ⅱ评分（APACHEⅡ）和多器官功能障碍综合征（MODS）评分,检测治疗前后血清胃动素（MTL）,胃泌素（GAS）,D-乳酸,二胺氧化酶（DAO）,降钙素原（PCT）,白细胞介素-6（IL-6）,IL-8,肿瘤坏死因子-α（TNF-α）水平;记录ICU病死率（2周内）,ICU住院日、机械通气时间。结果：观察组患者临床疗效愈显率为59.62%,高于对照组愈显率38.46%（χ^2=4.6564,P〈0.05）;观察组机械通气时间和ICU住院日均短于对照组（P〈0.01）,观察组ICU病死率11.54%,低于对照组病死率15.38%,组间比较差异无统计学意义;观察组患者CURB65,SMART-COP,CPIS,中医证候,GIDF,APACHEⅡ和MODS评分均低于对照组（P〈0.01）;观察组血清GAS,D-乳酸和DAO水平均低于对照组,MTL水平高于对照组（P〈0.01）;观察组患者血清PCT,TNF-α,IL-6和IL-8水平均低于对照组（P〈0.01）。结论：在西医常规治疗的基础上,宣肺通腑汤辅助治疗重症肺炎合并GIDF患者,可控制临床症状,调节胃肠激素,促进肠黏膜屏障修复和胃肠功能恢复,抑制炎症反应,减轻病情程度,缩短了疾病的愈合时间。展开更多
目的 探讨清肺通腑汤对重症肺炎痰热壅肺证患者肺功能、中医证候积分和炎症因子水平的影响。方法 选取80例重症肺炎痰热壅肺证患者,随机分为对照组与观察组各40例。对照组采用常规治疗,观察组在常规治疗的基础上采用清肺通腑汤治疗。比...目的 探讨清肺通腑汤对重症肺炎痰热壅肺证患者肺功能、中医证候积分和炎症因子水平的影响。方法 选取80例重症肺炎痰热壅肺证患者,随机分为对照组与观察组各40例。对照组采用常规治疗,观察组在常规治疗的基础上采用清肺通腑汤治疗。比较2组治疗前后中医证候积分(发热、咳嗽、气促等),肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV 1)、每分钟最大通气量(MVV)]和炎症因子[白细胞计数(WBC)、C反应蛋白(CRP)、白细胞介素-6(IL-6)]水平。结果 治疗2周后, 2组发热、咳嗽、气促积分均显著低于治疗前( P <0.05),且观察组显著低于对照组( P <0.05)。治疗 2周后, 2组FVC、FEV 1、MVV均显著高于治疗前( P <0.05),且观察组显著高于对照组( P <0.05)。治疗2周后, 2组WBC、CRP、IL-6均显著低于治疗前( P <0.05),且观察组显著低于对照组( P <0.05)。结论 重症肺炎痰热壅肺证采用中医清肺通腑汤治疗安全有效,可改善患者症状,抑制炎性反应,增强肺功能,促进患者康复。展开更多
基金Supported by Grants from the Natural Science Foundation of ChinaNo.2010Z131the Excellent Master Training Fund of the Second Military Medical University
文摘AIM:To investigate the efficacy and potential mechanism of Xiaotan Tongfu granules(XTTF)in stress ulcers.METHODS:One hundred sixty rats were randomly divided into 4 groups(n=10)as follows:the model group(MP group),the control group(CP group),the ranitidine group(RP group)and the XTTF granule group(XP group).Rats in the MP group received no drugs,rats in the CP group received 0.2 mL of a 0.9%sodium chloride solution via oral gavage,and rats in the RP and XP groups received the same volume of ranitidine(50 mg/kg)or XTTF granule(4.9 g/kg).The cold-restraint stress model was applied to induce stress ulcers after 7 consecutive days of drug administration.Afterwards,rats were sacrificed at 0,3,6 and24 h.Gastric pH was measured by a precise pH meter;gastric emptying rate(GER)was measured by using a methylcellulose test meal;myeloperoxidase activity(MPO),macrophage migration inhibitory factor(MIF),proliferating cell nuclear antigen(PCNA),and heat shock protein 70(HSP70)were measured by immunohistochemical staining;and mucosal cell apoptosis was measured by transferase dUTP nick end labeling.RESULTS:In the cold-restraint stress model,the development of stress ulcers peaked at 3 h and basically regressed after 24 h.Gastric lesions were significantly different in the RP and XP groups at each time point.Interestingly,although this index was much lower in the RP group than in the XP group immediately following stress induction(7.00±1.10 vs 10.00±1.79,P<0.05.Concerning gastric pH,between the RP and XP groups,we detected a statistically significant difference immediately after stress induction(0 h:4.56±0.47 vs 3.34±0.28,P<0.05)but not at any of the subsequent time points.For GER,compared to the RP group,GER was remarkably elevated in the XP group because a statistically significant difference was detected(3 h:46.84±2.70 vs 61.16±5.12,P<0.05;6 h:60.96±6.71 vs 73.41±6.16,P<0.05;24 h:77.47±3.17 vs 91.31±4.34,P<0.05).With respect to MPO and MIF,comparisons between the RP and XP groups revealed statistically significant di
文摘Objective. To observe the clinical efficacy and mechanism of Zhuyu Tongfu （逐瘀通腑, ZYTF） Serial Recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage （HCH）. Methods： One hundred and eighteen patients with hypertensive cerebral hemorrhage, on the basis of conventional Western medicine treatment, were randomly divided into ZYTF combined with acupuncture and massotherapy group （treated group） and simple Western medicine group （control group） ; the clinical efficacy, neurofunction deficit scoring （NDS） alterations and hematoma absorption rate of both groups were observed, and also the plasma superoxide dismutase （SOD） activity, plasma lipid peroxidase （LPO） content, erythrocyte glutathion peroxidase （GSH-Px） activity, hematocrit （Ht） and the whole blood viscosity （Va） change were also observed. Results： In the treated group, the clinical efficacy, NDS improvement and hematoma absorption rate were superior to that of the control group; comparison between the two groups after treatment showed that plasma SOD activity and GSH-Px activity got more elevated and plasma LPO content, Ht and Va more lowered in the the treated group than those in the control group. Cenclusien： ZYTF combined with acupuncture and massotherapy has better effect, its therapeutic mechanism was possibly correlated to the elevation of plasma SOD activity, GSH-Px activity and lowering of plasma LPO content, Ht and Va.
基金Key R&D Plan of Shaanxi Provincial Department of Science and Technology(No.2017ZDXM-SF-109)。
文摘Objective:To evaluate the efficacy and safety of XuanFei TongFu method in the treatment of sepsis.Methods:The relevant literatures on the treatment of sepsis by Xuanfei Tongfu method,published by PubMed,Medline and the Cochrane library,CNKI,WEIPU Database,WANFANG Database until December 2019 were searched by computer.Revman 5.3 was used to analyze the relevant literatures that met the inclusion and exclusion criteria,and to evaluate the influence of Xuanfei Tongfu method on gastrointestinal function,adverse reactions of gastrointestinal,28 day mortality.Results:a total of 17 randomized controlled clinical trials(RCTS)involving a total of 984 patients were included.Xuanfei Tongfu decoction combined with the control group can improve intestinal function.Xuanfei Tongfu decoction can reduce gastrointestinal adverse reactions,but there is no statistical significance,and reducing mortality of 28 days(RR=0.64,95%CI(0.42,0.99),P=0.04),reducing the APACHEⅡ[SMD=-0.90,95%CI(-1.49,-0.31),P=0.0003],reducing of Il-6[SMD=-0.36,95%CI(-0.62,-0.1),P=0.007],and improving IL-10 were all better than the control group,the difference was statistically significant.Conclusion:The method of Xuanfei Tongfu can enhance the gastrointestinal function,reduce the gastrointestinal adverse reactions,and improve the prognosis of sepsis patients.It may be achieved by regulating the body's immune inflammatory response.
文摘目的：观察宣肺通腑汤治疗中老年重症肺炎合并胃肠功能障碍的疗效及对胃肠功能的保护作用及对炎症因子的影响。方法：将104例符合要求的患者随机分为对照组和观察组各52例。对照组给予抗感染治疗、抗炎治疗、对症治疗及支持治疗,给予枸橼酸莫沙必利口服溶液,10 m L/次,3次/d,口服;双歧杆菌三联活菌散,2 g/次,3次/d,口服。观察组在对照组治疗的基础上给予宣肺通腑汤,1剂/d。两组疗程均连续治疗14 d。记录治疗前后CURB65,SMART-COP,临床肺部感染评分（CPIS）,中医证候评分、胃肠功能障碍（GIDF）,急性病生理和长期健康Ⅱ评分（APACHEⅡ）和多器官功能障碍综合征（MODS）评分,检测治疗前后血清胃动素（MTL）,胃泌素（GAS）,D-乳酸,二胺氧化酶（DAO）,降钙素原（PCT）,白细胞介素-6（IL-6）,IL-8,肿瘤坏死因子-α（TNF-α）水平;记录ICU病死率（2周内）,ICU住院日、机械通气时间。结果：观察组患者临床疗效愈显率为59.62%,高于对照组愈显率38.46%（χ^2=4.6564,P〈0.05）;观察组机械通气时间和ICU住院日均短于对照组（P〈0.01）,观察组ICU病死率11.54%,低于对照组病死率15.38%,组间比较差异无统计学意义;观察组患者CURB65,SMART-COP,CPIS,中医证候,GIDF,APACHEⅡ和MODS评分均低于对照组（P〈0.01）;观察组血清GAS,D-乳酸和DAO水平均低于对照组,MTL水平高于对照组（P〈0.01）;观察组患者血清PCT,TNF-α,IL-6和IL-8水平均低于对照组（P〈0.01）。结论：在西医常规治疗的基础上,宣肺通腑汤辅助治疗重症肺炎合并GIDF患者,可控制临床症状,调节胃肠激素,促进肠黏膜屏障修复和胃肠功能恢复,抑制炎症反应,减轻病情程度,缩短了疾病的愈合时间。
文摘目的 探讨清肺通腑汤对重症肺炎痰热壅肺证患者肺功能、中医证候积分和炎症因子水平的影响。方法 选取80例重症肺炎痰热壅肺证患者,随机分为对照组与观察组各40例。对照组采用常规治疗,观察组在常规治疗的基础上采用清肺通腑汤治疗。比较2组治疗前后中医证候积分(发热、咳嗽、气促等),肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV 1)、每分钟最大通气量(MVV)]和炎症因子[白细胞计数(WBC)、C反应蛋白(CRP)、白细胞介素-6(IL-6)]水平。结果 治疗2周后, 2组发热、咳嗽、气促积分均显著低于治疗前( P <0.05),且观察组显著低于对照组( P <0.05)。治疗 2周后, 2组FVC、FEV 1、MVV均显著高于治疗前( P <0.05),且观察组显著高于对照组( P <0.05)。治疗2周后, 2组WBC、CRP、IL-6均显著低于治疗前( P <0.05),且观察组显著低于对照组( P <0.05)。结论 重症肺炎痰热壅肺证采用中医清肺通腑汤治疗安全有效,可改善患者症状,抑制炎性反应,增强肺功能,促进患者康复。
